Immunoprofiler: Autoimmune Diseases

Status 1

Date

Photo

Description

Inspired by the success achieved profiling cancer, the team set out to develop a program that would profile autoimmune samples using a combination of proteomic, transcriptomic, epigenomic, and structural assays. The team utilizes streams of fresh clinical samples, which allows for the prospective collection of matched blood and tissue samples. In addition to collecting highly valuable clinical specimens, this also permits more uniform sample collection and processing, and ensures the ability to conduct cutting edge experimental assays. We anticipate assembling a consortium with at least four partners, enabling coverage of ~1,500 samples from patients with autoimmune diseases.

Status

Execution